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AbsTrACT
Circadian rhythms are endogenously generated recurring 
patterns of around 24 hours with well-established roles 
in physiology and behaviour. These circadian clocks 
are important in both the aetiology and treatment of 
various psychiatric and metabolic diseases. To maintain 
physiological homeostasis and optimal functioning, living 
life synchronised to these clocks is desirable; modern 
society, however, promotes a ’24/7’ lifestyle where 
activity often occurs during the body’s ’biological night’, 
resulting in mistimed sleep and circadian misalignment. 
This circadian desynchrony can increase the risk of 
disease and can also influence treatment response. 
Clinicians should be aware of the influence that circadian 
desynchrony can have on health and disease, in order 
to potentially develop new therapeutic strategies and to 
incorporate chronotherapeutics into current treatment 
strategies to enhance their utility.
InTroduCTIon
sleep and wake cycles in a rhythmic world
The award of the Nobel Prize for Physiology or 
Medicine in 2017 to the scientists who uncovered 
the mechanisms of circadian timing has highlighted 
an important, yet often overlooked, truth: we live in 
a rhythmic world. The daily rotation of the earth on 
its axis creates profound 24 hour variations in envi-
ronmental factors, such as temperature and light. 
Life on earth has evolved mechanisms to optimally 
exploit these changes, with the most obvious mani-
festation of this being the daily sleep/wake cycle. 
All mammals appear to have a biological need for 
sleep, with humans on average spending one-third 
of their lives asleep or trying to sleep.1 2 Sleep timing 
is regulated by two overlapping processes: the sleep 
dependent homeostatic drive for sleep, which accu-
mulates with increasing time spent in the awake 
state and the circadian process that imposes an 
underpinning rhythm of about 24 hours on sleep/
wake behaviour.3 4 The appropriate timing of sleep 
is emerging, along with other sleep parameters 
such as sleep quality and sleep duration, to be a key 
determinant of health and well-being. Poor sleep 
quality, short sleep duration and mistimed sleep 
are associated with an increased risk of disorders, 
pathologies and dysfunctions such as insulin resis-
tance, type 2 diabetes (T2DM), obesity, metabolic 
syndrome (MetS), cardiovascular disease and even 
all-cause mortality.5–8 As such, the processes that 
govern sleep are increasingly recognised as poten-
tial substrates for the improvement of health and 
the development of new therapeutic strategies (and 
better leveraging of existing approaches through 
chronotherapy).9
Circadian rhythms are recurring patterns of near 
24 hours that occur in all eukaryotic organisms 
independent of external factors and are driven by 
an organism’s endogenous clock.10 The molec-
ular basis of the circadian clock is a transcription-
al-translational autoregulatory feedback loop of 
the products of a panel of clock genes (including 
CLOCK, BMAL1, PER1/2, CRY1/2 and REV-ERB-a) 
which encode transcription factors. These clock 
gene products interlock in a series of feedback 
and feed-forward loops to regulate their own 
expression, with post-translational modifications 
tuning protein stability and turnover to produce 
a cycle with a period of near 24 hours.11 12 This 
clock gene cycle also imposes a pervasive temporal 
regulation on the transcriptome; in mouse, 40% 
of genes show rhythmic expression in at least one 
tissue.13 It is now recognised that there are molec-
ular clocks present in the vast majority of tissues 
and cell types, and that the circadian system is a 
network of oscillators distributed throughout the 
brain and periphery.14 Within this system, there is a 
master circadian pacemaker located in the suprachi-
asmatic nuclei (SCN) of the anterior hypothalamus; 
experimental lesion of the SCN results in profound 
circadian arrhythmicity and desynchronisation of 
peripheral oscillators.15
setting, and mis-setting, clock time
As the period of the circadian clock is approximately 
24 hours, a mechanism is required whereby this 
internal rhythm becomes synchronised (‘entrained’) 
to the external solar cycle. This entrainment occurs 
via the circadian phase being set by environmental 
time cues (‘zeitgebers’), with light being the most 
prominent entraining agent.16 Light input from the 
24 hour solar cycle is received by the master circa-
dian clock and conveyed to the peripheral clocks 
throughout the organism in order to achieve more 
precise, entrained 24 hour biological rhythms.17 
The master clock orchestrates and synchronises 
other brain and peripheral clocks to result in a 
coherent organism-wide regulation and integra-
tion of homeostasis and behaviour.18 An individu-
al's phase of entrainment reflects the relationship 
between external and internal time; interindividual 
differences in the circadian processes described 
above result in different chronotypes, and these 
are shaped by genotype, ontogeny, environment 
and gender.10 19 20 In humans, chronotype manifests 
itself as preferred sleep and wake times and ranges 
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Figure 1 The entrainment of the circadian clock. The 24 hour solar cycle entrains the endogenous circadian rhythm to a period of exactly 24 hours. 
Interindividual differences in this phase of entrainment shaped by genotype, environment, gender and age lead to different chronotypes whereby 
an individual is more morning or evening orientated, falling somewhere on the scale from an extreme morning person ‘lark’ to an extreme evening 
person ‘owl’.
Figure 2 Consequences of chronotype and circadian misalignment. (A) The typical day favours a morning orientated individual. A morning ‘lark’ 
displays psychological wellbeing as daily behavioural rhythms are aligned to the social work schedule. (B) Evening orientated individuals are likely to 
experience more sleep debt and circadian misalignment due to social/work schedules. The resultant misalignment may have various negative health 
and behavioural outcomes. BMI, body mass index; MDD, major depressive disorder; T2DM, type 2 diabetes; MetS, metabolic syndrome.
from extreme early types to extreme late types (see figure 1), 
with chronotype following a normal distribution in the general 
population and most of us falling somewhere in the middle.21 22
For most of human history, environmental light was provided 
predominantly by natural sunlight, with dawn and dusk time 
varying little between successive days. In current times, however, 
modern technology promotes a 24/7 society where individuals 
can work, socialise, travel and sleep during the body's biological 
night, the phase of the circadian cycle during which the endog-
enous clock is promoting sleep. Humans experience daily social 
pressures and imperatives, and these may vary greatly from day 
to day (eg, between work and free days). Social obligations can 
affect the alignment of an individual’s behavioural cycle to the 
endogenous biological rhythm, through altered sleep and wake 
times on work and free days, resulting in circadian misalign-
ment.23 24 This disruption may be temporary, as occurs with 
travel between time zones ‘jetlag’ or with society-wide changes 
to wake times via daylight savings time, or more permanent as 
with ongoing shift work. Night shift work, in particular, may 
result in profound circadian misalignment and many studies 
on shift workers have demonstrated the negative influence this 
can have on health.25 A milder, yet chronic, form of circadian 
misalignment is social jetlag (SJL). SJL is the daily and ongoing 
discrepancy between social time (when an individual's sleep and 
wake time is dictated by social or work obligations) and internal 
biological time.26 A large proportion of the population have 
social schedules that interfere with preferred sleep/wake sched-
ules, and individuals with an endogenous chronotype at greatest 
divergence from the societally determined sleep and wake times 
are at greater risk of developing SJL; in other words, late types 
(‘owls’) display sleep/wake preferences that do not conform to 
usual, earlier daily work schedules (see figure 2).
Given that the daily rhythmic expression of many vital homeo-
static functions (feeding, activity and rest, body temperature, 
hormone secretion, cardiac function, innate immunity, neuro-
physiology) are driven by the endogenous biological clock,27 it is 
perhaps not surprising that disruption of these rhythms is asso-
ciated with negative health and behavioural outcomes.23 There 
is an emerging understanding of the role of circadian clocks in 
many disease processes, and below we highlight evidence for the 
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role of clocks in the aetiology, symptomatology and treatment of 
psychiatric conditions and metabolic disorders.
CIrCAdIAn rhyThms And heAlTh
Circadian rhythms and psychiatric disorders
Reports of circadian rhythm disturbance in depression date back 
over 50 years.28 Patients with major depressive disorder (MDD) 
display altered daily patterns of affect, with the rhythms of low 
mood showing a later trough in the early morning and a blunted 
amplitude of the mood rhythm compared with controls (although 
mood is always lower in patients with depression irrespective of 
time-of-day).29 30 Patients with non-seasonal major depression 
show markedly later chronotypes and delayed sleep onsets than 
control populations.31–33 A recent review has supported this 
finding by reporting that the relationship between later chro-
notype and depression was well established in cross-sectional 
studies and that longitudinal studies are preliminarily reporting 
the same.34 This does not clarify the direction of this relation-
ship as late chronotype may be a marker and/or a risk factor for 
depression. A recent cross-sectional study from the UK BioBank 
revealed that MDD was also linked with a lower amplitude of 
the daily rest/activity rhythm.35 These findings indicate that a 
phase-delay of the circadian clock is associated with non-sea-
sonal depression, and this forms the basis for the use of bright-
light morning therapy as a treatment. The applicability of this 
as a treatment is based on our knowledge of the phase response 
curve; a light stimulus before the critical phase of the core body 
temperature minimum causes a phase delay while a light stim-
ulus after this critical phase causes a phase advance.36 37 With this 
phase delay observed in depression the clock’s phase is essen-
tially delayed to a later time zone, and early-morning light expo-
sure phase-advances the clock, and counteracts the pre-existing 
phase-delay. A recent randomised controlled trial demonstrated 
that morning light therapy or a combination or light therapy and 
fluoxetine were more effective than either fluoxetine alone or 
placebo in lessening depression symptoms.38
From a further chronotherapeutic perspective, underlying 
circadian phase may also modulate the efficacy of antidepres-
sant pharmacotherapy: recent research has demonstrated that 
evening types report lower SSRI (selective serotonin reuptake 
inhibitor) efficacy and more depressive symptoms during SSRI 
treatment,39 while a phase-delay after initiation of fluoxetine 
treatment predicted poorer treatment response in females.40 
There are currently no evidence-based guidelines for the time of 
dosing for various SSRI antidepressants, although animal studies 
indicate that fluoxetine can alter timing in the master clock of 
the SCN.41 The antidepressant agomelatine is a mixed mela-
tonin receptor agonist and 5HT-2C receptor antagonist with a 
putative primary mode of action through the circadian system 
and similar efficacy to SSRIs,42 a finding that further points to 
the potential clinical utility of targeting the circadian system for 
treatment of mood disorders.
Circadian factors are also associated with subclinical depressive 
symptoms. A recent meta-analysis identified that evening-ori-
entation is associated with more severe mood symptoms.43 A 
similar finding was demonstrated between evening orientated 
individuals and depressive symptoms in more recent research 
and poor sleep quality may mediate this relationship.44 In an 
adolescent population, evening types demonstrated more depres-
sive symptoms and a higher prevalence of depressogenic cogni-
tions.45 The impact of chronotype on symptoms of depression 
may be mediated through SJL, as adolescents and younger adults 
with later chronotypes experience greater levels of SJL, which in 
turn is associated with depressive symptoms.46 However, anal-
ysis of a patient sample with MDD and healthy controls found 
no association between SJL and depressive symptoms in either 
sample when the analysis was stratified.47 As SJL is a function of 
both intrinsic chronobiology and social factors such as employ-
ment status, and such factors are culturally-determined and also 
heavily influenced by age, further study in diverse populations 
is required.
Seasonal depression has long been associated with changes in 
the circadian system in response to changes in the photoperiod 
across the year.48 Winter depression, the most common mani-
festation of seasonal affective disorder (SAD), may coprecipitate 
with changes in sleep parameters including lower sleep efficiency, 
shorter sleep time, more sleep inertia, longer sleep latencies and 
later sleep and waking time.49 Two-thirds of patients with winter 
depression display phase delays of the dim-light melatonin onset 
(a key marker of circadian phase), while one-third display phase 
advances.50 Further, treatment with light therapy and melatonin 
timed appropriately to counteract the underlying phase shift 
alleviated the symptoms of SAD. Intrinsic circadian characteris-
tics may be a risk factor for SAD; there is a relationship between 
SAD and diurnal preference,51 adolescents with later chronotype 
display higher mood seasonality52 and SJL may also elevate SAD 
risk in females.49 However, chronotherapy approaches have so 
far not been proved to be effective in preventing SAD.53
Circadian disruptions and alterations in circadian parameters 
have been reported in patients with bipolar disorder (BD). A 
recent systematic review reports phase delays in daily cortisol 
and melatonin rhythms, and depression (more so than during 
euthymia) was associated with circadian disruption.54 Interest-
ingly, some studies showed more sleep/social rhythm dysreg-
ulation in BD than MDD.55 It has long been recognised that 
alterations in circadian timing, for example as a result of jetlag, 
can precipitate mood cycling in BD,56 and a recent study has 
demonstrated that in rapidly cycling BD, sleep/wake cycles 
appear to synchronise to the lunar cycle through an unknown 
mechanism.57 From a chronotherapy perspective, mood stabi-
lisers such as lithium are known to impact directly on the core 
molecular clockworks;58 further, chronotherapy involving bright 
light therapy in combination with sleep deprivation has been 
shown to elicit a rapid and long-lasting amelioration of bipolar 
depression.59–61 From a mechanistic perspective, a number of 
cellular and molecular processes have been identified to interact 
with the clock and modulate mood, including hypothalam-
ic-pituitary-adrenal axis function, immune and neuroimmune 
processes, neurogenesis and direct control of neurotransmitter 
and neuromodulator systems.62 Circadian changes have also been 
described in a number of other psychiatric conditions, including 
schizophrenia,63 attention deficit hyperactivity disorder,64 obses-
sive compulsive disorder65 and borderline personality disorder.66 
As such, circadian processes appear to be important transdiag-
nostic factors to consider in psychiatry and clinical psychology.
Circadian rhythms and metabolic health
Given the pervasive influence of the circadian clock in regulating 
homeostasis and physiology, it is not surprising that circadian 
rhythms are associated with multiple facets of physical health.67 
Furthermore, since a central function of the circadian system is 
to provide a temporal organisation of metabolism that synchro-
nises with behavioural rhythms and likely environmental avail-
ability of food, circadian processes have been strongly implicated 
in metabolic health. An important finding in this regard was 
the discovery that mice deficient in the circadian CLOCK gene 
demonstrated higher levels of obesity and more weight gain on 
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main messages
 ► Circadian rhythms, and the rhythmic nature of the world, 
have emerged as key factors in health and well-being, with 
circadian misalignment and mistimed sleep being associated 
with various pathologies and risk of disorders.
 ► Major depressive disorder has been associated with a later 
chronotype which may act as a risk factor for developing 
depressive symptoms or also occur as a result of depressive 
symptoms. The use of bright light therapy to advance this 
phase may decrease depression severity and also improve 
existing treatment. The circadian system needs to be used 
further to reduce the burden of mood disorders.
 ► Research is accumulating for the independent role that 
social jetlag (SJL) and chronotype may play in metabolic 
health. SJL has been associated with higher body mass index, 
increased risk of type 2 diabetes and metabolic syndrome 
even when confounding variables are controlled for, while 
later chronotype has been associated with diabetes risk and 
management. Novel behavioural interventions to reduce SJL 
that promote having more regular schedules across the week 
may be simple yet important in both preventing and treating 
these metabolic diseases.
Current research questions
1. What is the nature of the relationship between the 
circadian system and mood disorders? Is the relationship 
between depressive symptoms and chronotype due to 
evening orientation or does social jetlag (SJL) mediate this 
relationship? As such, what chronotherapeutic approach 
could be used or would a simple behavioural intervention be 
of use to reduce symptoms?
2. How beneficial will simple novel behavioural interventions to 
reduce SJL be for decreasing the risk of developing various 
metabolic disorders as well as treating them?
3. What is the causal relationship between chronotype and both 
mood disorders and metabolic dysfunction?
both a regular and high fat diet when compared with wild-type 
controls and also displayed features of the metabolic syndrome 
including hyperglycaemia and hypoinsulinaemia.68 The develop-
ment of many metabolic disorders including obesity, T2DM and 
MetS has also been linked to genetic variations in the CLOCK 
gene in human populations.69–71 These CLOCK polymorphisms 
have been associated with greater total energy intake,71 and the 
resulting haplotypes have been suggested to influence obesity 
susceptibility.70 Metabolic homeostasis is affected, therefore, by 
circadian genotype.12 Fundamental research has shown that the 
circadian clocks serve to regulate metabolism and energy homeo-
stasis in a tissue-specific manner through molecular pathways 
that include NAD+-dependent Sirtuin signalling, haem biosyn-
thesis, fatty acid biosynthesis, glucose metabolism and insulin 
release.72 Environmentally induced circadian disruption is also 
associated with metabolic derangement; forced desynchronisa-
tion of the circadian and sleep/wake and feeding cycle in human 
participants results in hyperglycaemia and insulin resistance 
indicative of a prediabetic state.73 Circadian desynchronisa-
tion is likely experienced by shift workers who undertake night 
work, and shift work is associated with elevated risk of T2DM 
of approximately 40% for those with an established history 
of night work, an effect that is independent of genetic risk for 
T2DM.74 A recent study has also demonstrated that in simulated 
shift work, the metabolic rhythms follow the behavioural, but 
not the circadian, cycle.75
As mentioned above, SJL may represent a more common, 
milder, but chronic form of circadian misalignment occurring 
with high prevalence in the general population. Notably, research 
on the independent association between SJL and metabolic health 
is growing. In three large cohort studies, SJL has been associated 
with increased body mass index (BMI) (independently of other 
health parameters and short sleep), and particularly associated 
with risk of moving to obesity from overweight.76–78 A recent 
cross-sectional study identified a twofold increased risk of both 
pre-diabetes/diabetes and MetS in individuals below 61 years 
with high SJL.79 This study demonstrated a prevalence ratio for 
MetS of 2.13 and diabetes/prediabetes of 1.75 for participants 
with more than 2 hours of SJL and a prevalence ratio of 1.29 
and 1.39, respectively for those with 1–2 hours SJL compared to 
those with SJL of less than 1 hour. These findings have recently 
been replicated in a Japanese population with greater likelihood 
of having MetS and SJL being associated.80 Furthermore, this 
research demonstrated that the relationship between SJL and 
MetS persisted after adjusting for various confounding vari-
ables such as alcohol consumption, sleep quality, caloric intake, 
breakfast skipping and leisure time exercise. SJL has also been 
associated with higher BMI, triglycerides, fasting plasma insulin, 
insulin resistance and greater fat mass.77 78 For patients with 
non-communicable chronic disorders, SJL and fasting glucose 
were associated, most so in metabolically unhealthy obese 
(MUO) participants; SJL was also associated with higher risk 
of being obese and fitting the MUO category and thus risked 
metabolic complications.81 Chronotype is also associated with 
diabetes and obesity risk, with individuals with a later chrono-
type having an increased likelihood of T2DM compared with 
morning types with a 2.5 fold OR.82 In addition to this, a recent 
study from the UK BioBank comparing definite evening and defi-
nite morning types identified an increased likelihood of diabetes 
in evening orientated individuals with an OR of 1.30.8 Later 
chronotype is associated with higher HbA1c levels, indepen-
dent of confounding sleep and clinical variables, in T2DM83 and 
prediabetes.84 There are conflicting reports of the association 
of chronotype with glycaemic control in type 1 diabetes: one 
study reports that more SJL is associated with poorer glycaemic 
control in adults,85 while in an adolescent cohort chronotype or 
SJL was not associated with HbA1c levels.86
ConClusIon
It is clear that the endogenous circadian clock plays a crucial role in 
various aspects of health, with increasing evidence demonstrating 
the important roles of the clock in both disease risk and manage-
ment. Further work is needed to incorporate the circadian concept 
into the core of medicine in order to maximise its potential for 
disease prevention and treatment.
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self assessment questions
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